Alphavax, of Research Triangle Park, reported completing preclinical work and is developing product for clinical trials of its H1N1 (Swine Flu) vaccine, per company press release (click here).
GlaxoSmithKline (GSK) tasks order for 195 million doses of vaccine
The Times (UK) click here
GlaxoSmithKline (GSK) tasks order for 195 million doses of vaccine
The Times (UK) click here
Comments